The global Albendazole market size was valued at US$ 178 million in 2024 and is forecast to a readjusted size of USD 295 million by 2031 with a CAGR of 7.6% during review period.
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite"s absorption of glucose, leading to depletion of the body"s glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK"s albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
This report is a detailed and comprehensive analysis for global Albendazole market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Albendazole market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Albendazole market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Albendazole market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Albendazole market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Albendazole
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Albendazole market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd, Supharma Chem, Salius Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Albendazole market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Tablet
Capsule
Other
麻豆原创 segment by Application
Human
Veterinary
Major players covered
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Albendazole product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albendazole, with price, sales quantity, revenue, and global market share of Albendazole from 2020 to 2025.
Chapter 3, the Albendazole competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albendazole breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Albendazole market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albendazole.
Chapter 14 and 15, to describe Albendazole sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Albendazole Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Other
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Albendazole Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Human
1.4.3 Veterinary
1.5 Global Albendazole 麻豆原创 Size & Forecast
1.5.1 Global Albendazole Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Albendazole Sales Quantity (2020-2031)
1.5.3 Global Albendazole Average Price (2020-2031)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Albendazole Product and Services
2.1.4 GlaxoSmithKline Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Huazhong Pharmaceutical
2.2.1 Huazhong Pharmaceutical Details
2.2.2 Huazhong Pharmaceutical Major Business
2.2.3 Huazhong Pharmaceutical Albendazole Product and Services
2.2.4 Huazhong Pharmaceutical Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Huazhong Pharmaceutical Recent Developments/Updates
2.3 Jiangsu Qihui
2.3.1 Jiangsu Qihui Details
2.3.2 Jiangsu Qihui Major Business
2.3.3 Jiangsu Qihui Albendazole Product and Services
2.3.4 Jiangsu Qihui Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Jiangsu Qihui Recent Developments/Updates
2.4 Sequent Scientific
2.4.1 Sequent Scientific Details
2.4.2 Sequent Scientific Major Business
2.4.3 Sequent Scientific Albendazole Product and Services
2.4.4 Sequent Scientific Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Sequent Scientific Recent Developments/Updates
2.5 K.A. Malle Pharmaceuticals
2.5.1 K.A. Malle Pharmaceuticals Details
2.5.2 K.A. Malle Pharmaceuticals Major Business
2.5.3 K.A. Malle Pharmaceuticals Albendazole Product and Services
2.5.4 K.A. Malle Pharmaceuticals Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 K.A. Malle Pharmaceuticals Recent Developments/Updates
2.6 Lasa Supergenerics Limited
2.6.1 Lasa Supergenerics Limited Details
2.6.2 Lasa Supergenerics Limited Major Business
2.6.3 Lasa Supergenerics Limited Albendazole Product and Services
2.6.4 Lasa Supergenerics Limited Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Lasa Supergenerics Limited Recent Developments/Updates
2.7 Zhongjia Pharmaceutical
2.7.1 Zhongjia Pharmaceutical Details
2.7.2 Zhongjia Pharmaceutical Major Business
2.7.3 Zhongjia Pharmaceutical Albendazole Product and Services
2.7.4 Zhongjia Pharmaceutical Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Zhongjia Pharmaceutical Recent Developments/Updates
2.8 Fredun Pharmaceuticals Ltd
2.8.1 Fredun Pharmaceuticals Ltd Details
2.8.2 Fredun Pharmaceuticals Ltd Major Business
2.8.3 Fredun Pharmaceuticals Ltd Albendazole Product and Services
2.8.4 Fredun Pharmaceuticals Ltd Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Fredun Pharmaceuticals Ltd Recent Developments/Updates
2.9 Supharma Chem
2.9.1 Supharma Chem Details
2.9.2 Supharma Chem Major Business
2.9.3 Supharma Chem Albendazole Product and Services
2.9.4 Supharma Chem Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Supharma Chem Recent Developments/Updates
2.10 Salius Pharma
2.10.1 Salius Pharma Details
2.10.2 Salius Pharma Major Business
2.10.3 Salius Pharma Albendazole Product and Services
2.10.4 Salius Pharma Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Salius Pharma Recent Developments/Updates
3 Competitive Environment: Albendazole by Manufacturer
3.1 Global Albendazole Sales Quantity by Manufacturer (2020-2025)
3.2 Global Albendazole Revenue by Manufacturer (2020-2025)
3.3 Global Albendazole Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Albendazole by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Albendazole Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Albendazole Manufacturer 麻豆原创 Share in 2024
3.5 Albendazole 麻豆原创: Overall Company Footprint Analysis
3.5.1 Albendazole 麻豆原创: Region Footprint
3.5.2 Albendazole 麻豆原创: Company Product Type Footprint
3.5.3 Albendazole 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Albendazole 麻豆原创 Size by Region
4.1.1 Global Albendazole Sales Quantity by Region (2020-2031)
4.1.2 Global Albendazole Consumption Value by Region (2020-2031)
4.1.3 Global Albendazole Average Price by Region (2020-2031)
4.2 North America Albendazole Consumption Value (2020-2031)
4.3 Europe Albendazole Consumption Value (2020-2031)
4.4 Asia-Pacific Albendazole Consumption Value (2020-2031)
4.5 South America Albendazole Consumption Value (2020-2031)
4.6 Middle East & Africa Albendazole Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Albendazole Sales Quantity by Type (2020-2031)
5.2 Global Albendazole Consumption Value by Type (2020-2031)
5.3 Global Albendazole Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Albendazole Sales Quantity by Application (2020-2031)
6.2 Global Albendazole Consumption Value by Application (2020-2031)
6.3 Global Albendazole Average Price by Application (2020-2031)
7 North America
7.1 North America Albendazole Sales Quantity by Type (2020-2031)
7.2 North America Albendazole Sales Quantity by Application (2020-2031)
7.3 North America Albendazole 麻豆原创 Size by Country
7.3.1 North America Albendazole Sales Quantity by Country (2020-2031)
7.3.2 North America Albendazole Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Albendazole Sales Quantity by Type (2020-2031)
8.2 Europe Albendazole Sales Quantity by Application (2020-2031)
8.3 Europe Albendazole 麻豆原创 Size by Country
8.3.1 Europe Albendazole Sales Quantity by Country (2020-2031)
8.3.2 Europe Albendazole Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Albendazole Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Albendazole Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Albendazole 麻豆原创 Size by Region
9.3.1 Asia-Pacific Albendazole Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Albendazole Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Albendazole Sales Quantity by Type (2020-2031)
10.2 South America Albendazole Sales Quantity by Application (2020-2031)
10.3 South America Albendazole 麻豆原创 Size by Country
10.3.1 South America Albendazole Sales Quantity by Country (2020-2031)
10.3.2 South America Albendazole Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Albendazole Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Albendazole Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Albendazole 麻豆原创 Size by Country
11.3.1 Middle East & Africa Albendazole Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Albendazole Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Albendazole 麻豆原创 Drivers
12.2 Albendazole 麻豆原创 Restraints
12.3 Albendazole Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Albendazole and Key Manufacturers
13.2 Manufacturing Costs Percentage of Albendazole
13.3 Albendazole Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Albendazole Typical Distributors
14.3 Albendazole Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
听
听
*If Applicable.
